Meeting
2015 ASCO Annual Meeting
A randomized phase II study of TS-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small cell lung cancer (LA-NSCLC): WJOG 5008L.
Authors
Takashi Seto
National Kyushu Cancer Center, Fukuoka, Japan
Takashi Seto , Tomonari Sasaki , Takeharu Yamanaka , Naonobu Kunitake , Junichi Shimizu , Takeshi Kodaira , Makoto Nishio , Takuyo Kozuka , Toshiaki Takahashi , Hideyuki Harada , Naruo Yoshimura , Shinichi Tsutsumi , Hiromoto Kitajima , Masaaki Kataoka , Kazuhiko Nakagawa , Yasumasa Nishimura , Yoichi Nakanishi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Clinical Trial Registration Number
000002420
Citation
J Clin Oncol 33, 2015 (suppl; abstr 7512)
DOI
10.1200/jco.2015.33.15_suppl.7512
Abstract #
7512
Poster Bd #
259
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial.
First Author: Thiago Bueno Oliveira Sr.
Poster
2018 ASCO Annual Meeting
Carboplatin (CBDCA), S-1 and concurrent thoracic radiotherapy (TRT) for elderly patients with locally advanced non-small cell lung cancer (NSCLC): A phase II study.
First Author: Seiji Niho
Poster
2017 ASCO Annual Meeting
Randomized phase II trial of S-1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer (TORG1018).
First Author: Kaoru Kubota
First Author: Hidehito Horinouchi